JOIN THE EVENT Why attend care4cancer
Invitation Comprehensive Advancements in Research and Exchanges for Neuro-Oncology
LISTEN TO THE International Speakers
Anca Ligia Grosu, MD, PhD
Radiation Oncologist
Anca Ligia Grosu, MD, PhD
Radiation Oncologist
Director of the Radiation Oncology department, University Medical Center, Freiburg
Member of the Executive Committee of the German Neurooncology Association
Chair of the Hans-Langendorff Committee
Anca-Ligia Grosu, MD, PhD, Medical Director of the Department of Radiation Oncology at the University Medical Center Freiburg, was recently awarded the prestigious Alfred Breit Prize for her outstanding scientific research in the field of integrating medical/biological imaging into the radiotherapy planning process. The Alfred Breit Prize is awarded annually by the German Society for Radiation Oncology (Deutschen Gesellschaft für Radioonkologie - DEGRO) and is one of the most prestigious scientific awards in the field.
Dr. Grosu and her team developed a number of new methods that allow for improved precision in radiation therapy using biological imaging. Their research opens up an important pathway to personalized cancer therapy, enabling more precise targeting of radiation and better protection of healthy tissue around tumors.
Dr. Grosu studied medicine at the University of Cluj-Napoca, Romania, and then worked at the Rechts der Isar Clinic of the Technical University of Munich (1990-2006). After a year of research at Harvard Medical School in Boston, USA, she became the Director of the Department of Radiology and Radiation Oncology at the University Medical Center Freiburg in 2007. In 2018, she was elected a member of the German National Academy of Sciences Leopoldina, and in January 2020, she became the Vice-Chair of the Leopoldina's Section of Radiology.
The Alfred Breit Prize is named after one of the pioneers of modern radiotherapy, Professor Dr. Alfred Breit, and has been awarded annually by DEGRO since 2012. The prize is awarded to recognize outstanding scientific research in the field of radiation oncology that is expected to make significant contributions to cancer therapy.
Maria Fleșeriu, MD, FACE
Neuroendocrinologist, Director pituitary center
Maria Fleșeriu, MD, FACE
Neuroendocrinologist, Director pituitary center
Maria Fleseriu, MD, FACE is a Professor of Medicine and Neurological Surgery, Director of the Pituitary Center at Oregon Health and Science University in Portland, Oregon, USA, and Past President of the Pituitary Society. Dr. Fleseriu has a long-standing clinical and research interest in the pathophysiology and treatment of pituitary and adrenal disorders. She has received many national and international awards, including title of “Doctor Honors Causa” by the University of Medicine and Pharmacy “Carol Davila” and the Clinical Endocrinology Trust Award from the U.K Society of Endocrinology. She is a frequent plenary guest speaker at national and international meetings and is Deputy Editor for European Journal of Endocrinology, Associate Editor for Reviews of Endocrinology and Metabolism and a member in many editorial boards, including Pituitary. Dr. Fleseriu has been global principal investigator in many pituitary disorders clinical trials and has authored over 250 manuscripts in prestigious high impact journals, including novel treatments, international guidelines and consensus papers for Cushing’s, acromegaly and hypopituitarism. She has been elected and serves now as a member of the Executive Board of Pituitary Society and of the Board of Directors of Endocrine Society, the largest international society in the world with over 18000 members. Topic: Medical treatment of pituitary tumors, can we replace surgery
Alfredo Quinones-Hinojosa, M.D.
Neurosurgeon
Alfredo Quinones-Hinojosa, M.D.
Neurosurgeon
Alfredo Quinones-Hinojosa, M.D., is a consultant and serves as chair of the Department of Neurologic Surgery at Mayo Clinic's campus in Florida, and he is recognized with the distinction of a named professorship, the William J. and Charles H. Mayo Professorship. His clinical focus includes:
Surgical treatment of primary and metastatic brain tumors with emphasis in motor and speech mapping during surgery
Surgical management of Intramedullary Spinal Cord Tumors/lesions with Spine Mapping
Pituitary tumors and skull base tumors using transsphenoidal endonasal and minimally invasive approaches
Providing personalized medicine to improve patient outcomes
In addition to his clinical activities, Dr. Quinones-Hinojosa leads NIH-funded research to find a cure for brain cancer. His cutting-edge research focuses on brain tumors and cell migration, health care disparities and clinical outcomes for neurosurgical patients in which the operating room is used as an extension for his research scenario. He has authored numerous high-impact scientific journal articles, chapters, abstracts and books.
Dr. Quinones-Hinojosa also continues to provide mentorship to residents, graduate students and fellows.
Claudiu Matei, MD, PhD
Head of Neurosurgery Division MedLife Polisano
EN 
RO